Prospera Financial Services Inc Sells 4,087 Shares of SPDR S&P Biotech ETF $XBI

Prospera Financial Services Inc cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,877 shares of the exchange traded fund’s stock after selling 4,087 shares during the quarter. Prospera Financial Services Inc’s holdings in SPDR S&P Biotech ETF were worth $1,449,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. AQR Capital Management LLC increased its stake in SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock worth $404,000 after purchasing an additional 2,167 shares during the period. Marshall Wace LLP increased its stake in SPDR S&P Biotech ETF by 102.3% in the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after purchasing an additional 179,029 shares during the period. The Manufacturers Life Insurance Company purchased a new stake in SPDR S&P Biotech ETF in the second quarter worth $260,000. Ameriprise Financial Inc. increased its stake in SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock worth $72,542,000 after purchasing an additional 481,408 shares during the period. Finally, EP Wealth Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.7% in the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock worth $446,000 after purchasing an additional 193 shares during the period.

SPDR S&P Biotech ETF Trading Up 0.8%

Shares of SPDR S&P Biotech ETF stock opened at $134.45 on Thursday. The firm has a market cap of $8.58 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12 month low of $78.06 and a 12 month high of $139.19. The stock’s fifty day moving average price is $130.44 and its 200-day moving average price is $125.67.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.